- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02414217
Intervention to Enhance Numeracy in Diabetes (IntEND) (IntEND)
September 21, 2017 updated by: University of Colorado, Denver
Intervention to Enhance Numeracy in Diabetes
The objective of this project is to test two interventions designed to improve diabetes-related numeracy.
Numeracy is the ability to understand and use numbers.
People with diabetes use numbers in a variety of ways in managing their condition (e.g., understanding blood sugar values, counting carbohydrates, taking medications at the right dose and time).
As part of this project, the investigators developed and pilot tested two interventions to improve diabetes-related numeracy: (1) a series of in-person education classes and (2) a one-time, online diabetes education class.
The investigators will look to see whether participants in the education classes show improvements in their diabetes-related numeracy skills, self-care behavior and attitudes, and clinical outcomes (i.e., body mass index, blood pressure, blood sugar [A1c]).
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
Sixty-five American Indians with diabetes were enrolled.
Each participant was randomly assigned to 1 of 3 study arms: (1) the in-person education group, (2) the online education group, and (3) a control group.
The in-person intervention group attended four class sessions addressing numeracy skills used in the management of diabetes (e.g., counting carbohydrates).
The online education group completed a single online module providing training on diabetes-related numeracy skills.
The control group received written diabetes educational materials.
The investigators collected data at baseline, then again immediately after intervention participation (in-person or online classes), and one final time about three months after the conclusion of the intervention.
The investigators will conduct analyses to determine if intervention participants experienced positive changes in diabetes numeracy (the primary outcome) as well as several secondary outcome measures following intervention.
Secondary outcomes include: diabetes knowledge, self-efficacy, outcome expectancies, readiness to change, self-care behavior, and clinical outcomes (i.e., body mass index, blood pressure, blood sugar [A1c]) .
The investigators also will assess whether change in numeracy predicts change in these secondary outcomes.
Study Type
Interventional
Enrollment (Actual)
65
Phase
- Not Applicable
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 89 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- American Indian/Alaska Native;
- 18 to 89 years old;
- diabetes diagnosis documented in medical records;
- active patient of the Yakama Indian Health Service.
Exclusion Criteria:
- Does not speak English;
- pregnancy;
- dialysis;
- current cancer treatment;
- blindness;
- active alcohol/substance abuse;
- planning to move out of the area in the next six months.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: In-Person Diabetes Numeracy Education
Participants randomized to the in-person education group attended four group classes, each addressing a specific set of diabetes self-care skills (i.e., understanding and using blood glucose numbers, counting carbohydrates, taking medications at the right dose and time).
So that each class included a stable group of 8 and 16 participants, we ran classes in "cohorts" of 8-16 people.
A participant always attended classes with his/her cohort.
|
Participants randomized to the in-person education group attended four group classes, each addressing a specific set of diabetes self-care skills (i.e., understanding and using blood glucose numbers, counting carbohydrates, taking medications at the right dose and time).
So that each class included a stable group of 8 and 16 participants, we ran classes in "cohorts" of 8-16 people.
A participant always attended classes with his/her cohort.
Other Names:
|
Experimental: Online Diabetes Numeracy Education
Participants randomized to the online education group attended a single session, at which he/she completed a computerized education module that addressed understanding blood sugar values and using them to examine the impact of food, exercise, and medicines on blood sugar.
|
Participants randomized to the online education group attended a single session, at which he/she completed a computerized education module that addressed understanding blood sugar values and using them to examine the impact of food, exercise, and medicines on blood sugar.
Other Names:
|
No Intervention: Control
Participants were given written educational materials about diabetes.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change in Objective Diabetes Numeracy from Baseline to ≈6 weeks
Time Frame: ≈6 weeks
|
Adapted version of the Diabetes Numeracy Test
|
≈6 weeks
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change in Objective Diabetes Numeracy from Baseline to ≈3 months
Time Frame: ≈3 months
|
Adapted version of the Diabetes Numeracy Test
|
≈3 months
|
Change in Subjective Numeracy from Baseline to ≈6 weeks
Time Frame: ≈6 weeks
|
Subjective Numeracy Scale
|
≈6 weeks
|
Change in Subjective Numeracy from Baseline to ≈3 months
Time Frame: ≈3 months
|
Subjective Numeracy Scale
|
≈3 months
|
Change in Diabetes Knowledge from Baseline to ≈6 weeks
Time Frame: ≈6 weeks
|
Adapted version of the Diabetes Knowledge Test
|
≈6 weeks
|
Change in Diabetes Knowledge from Baseline to ≈3 months
Time Frame: ≈3 months
|
Adapted version of the Diabetes Knowledge Test
|
≈3 months
|
Change in Diabetes Self-Efficacy from Baseline to ≈6 weeks
Time Frame: ≈6 weeks
|
Adapted items from existing instruments
|
≈6 weeks
|
Change in Diabetes Self-Efficacy from Baseline to ≈3 months
Time Frame: ≈3 months
|
Adapted items from existing instruments
|
≈3 months
|
Change in Outcome Expectancies from Baseline to ≈6 weeks
Time Frame: ≈6 weeks
|
Adapted items from existing instruments
|
≈6 weeks
|
Change in Outcome Expectancies from Baseline to ≈3 months
Time Frame: ≈3 months
|
Adapted items from existing instruments
|
≈3 months
|
Change in Readiness to Change from Baseline to ≈6 weeks
Time Frame: ≈6 weeks
|
Newly developed items
|
≈6 weeks
|
Change in Readiness to Change from Baseline to ≈3 months
Time Frame: ≈3 months
|
Newly developed items
|
≈3 months
|
Change in Diabetes Self-Care Behavior from Baseline to ≈6 weeks
Time Frame: ≈6 weeks
|
Summary of Diabetes Self-Care Activities Scale plus additional relevant items
|
≈6 weeks
|
Change in Diabetes Self-Care Behavior from Baseline to ≈3 months
Time Frame: ≈3 months
|
Summary of Diabetes Self-Care Activities Scale plus additional relevant items
|
≈3 months
|
Change in Body Mass Index from Baseline to ≈6 weeks
Time Frame: ≈6 weeks
|
Body Mass Index
|
≈6 weeks
|
Change in Body Mass Index from Baseline to ≈3 months
Time Frame: ≈3 months
|
Body Mass Index
|
≈3 months
|
Change in Blood Pressure from Baseline to ≈6 weeks
Time Frame: ≈6 weeks
|
Systolic and Diastolic Blood Pressure
|
≈6 weeks
|
Change in Blood Pressure from Baseline to ≈3 months
Time Frame: ≈3 months
|
Systolic and Diastolic Blood Pressure
|
≈3 months
|
Change in Glycemic Control from Baseline to ≈3 months
Time Frame: ≈3 months
|
Hemoglobin A1c
|
≈3 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Angela G. Brega, PhD, University of Colorado - Anschutz Medical Campus
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
July 1, 2015
Primary Completion (Actual)
February 1, 2016
Study Completion (Actual)
October 31, 2016
Study Registration Dates
First Submitted
April 2, 2015
First Submitted That Met QC Criteria
April 7, 2015
First Posted (Estimate)
April 10, 2015
Study Record Updates
Last Update Posted (Actual)
September 25, 2017
Last Update Submitted That Met QC Criteria
September 21, 2017
Last Verified
September 1, 2017
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 13-0229
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Diabetes
-
University of Colorado, DenverMassachusetts General Hospital; Beta Bionics, Inc.CompletedDiabetes Mellitus, Type 1 | Type 1 Diabetes | Diabetes type1 | Type 1 Diabetes Mellitus | Autoimmune Diabetes | Diabetes Mellitus, Insulin-Dependent | Juvenile-Onset Diabetes | Diabetes, Autoimmune | Insulin-Dependent Diabetes Mellitus 1 | Diabetes Mellitus, Insulin-Dependent, 1 | Diabetes Mellitus, Brittle | Diabetes Mellitus, Juvenile-Onset and other conditionsUnited States
-
Guang NingRecruitingType 2 Diabetes Mellitus | Type1 Diabetes Mellitus | Monogenetic Diabetes | Pancreatogenic Diabetes | Drug-Induced Diabetes Mellitus | Other Forms of Diabetes MellitusChina
-
University of Trás-os-Montes and Alto DouroCompletedType 2 Diabetes Mellitus | Diabetes-Related ComplicationsPortugal
-
Northern Care Alliance NHS Foundation TrustBrighter ABCompletedDiabetes type1 | Diabetes type2United Kingdom
-
VeraLight, Inc.InLight SolutionsUnknownGestational Diabetes | Insulin Dependent Diabetes | Non Insulin Dependent DiabetesUnited States
-
Garvan Institute of Medical ResearchWeizmann Institute of ScienceActive, not recruitingType 2 Diabetes Mellitus | Pre DiabetesAustralia
-
Oregon State UniversitySanofiCompletedType I or Type II Diabetes (Excludes Gestational Diabetes)
-
Taichung Veterans General HospitalNational Health Research Institutes, TaiwanRecruitingDiabetes Complications | Type 2 Diabetes | Maturity-Onset Diabetes of the Young (MODY)Taiwan
-
Peking Union Medical College HospitalUnknownType 2 Diabetes Mellitus | Type 1 Diabetes Mellitus | Gestational Diabetes Mellitus | Pancreatogenic Diabetes Mellitus | Pregestational Diabetes Mellitus | Diabetes Patients in Perioperative PeriodChina
-
University of RoehamptonRecruitingType2 Diabetes Mellitus | Pre DiabetesUnited Kingdom
Clinical Trials on In-Person Diabetes Numeracy Education
-
State University of New York - Upstate Medical...TerminatedDiabetes MellitusUnited States
-
Columbia UniversityNational Cancer Institute (NCI)Completed
-
University of Rome Tor VergataRecruiting
-
Montefiore Medical CenterTerminatedSexual Dysfunction | Amputation; Traumatic, Limb | Diabetic Ulcers on Both Feet | Diabetic Foot Ulcer IschemicUnited States
-
Cyprus University of TechnologyUniversity of AthensUnknown
-
Kaiser PermanenteCompletedObesity | Diabetes Mellitus, Type 2 | OverweightUnited States
-
Northwestern UniversityCompletedMelanomaUnited States
-
National Taiwan University HospitalRecruitingType 2 DiabetesTaiwan
-
Sansum Diabetes Research InstituteAbbott; DexCom, Inc.RecruitingCardiovascular Diseases | Diabetes Mellitus, Type 2United States
-
Ann & Robert H Lurie Children's Hospital of ChicagoCompletedType 1 DiabetesUnited States